Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.02 USD | -0.59% | 0.00% | -1.38% |
Financials (USD)
Sales 2022 | 18.57M | Sales 2023 | 17.47M | Capitalization | 39.45M |
---|---|---|---|---|---|
Net income 2022 | -2M | Net income 2023 | -5M | EV / Sales 2022 | 2.91 x |
Net Debt 2022 | 6.69M | Net Debt 2023 | 15.71M | EV / Sales 2023 | 3.16 x |
P/E ratio 2022 |
-18.9
x | P/E ratio 2023 |
-6.79
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 71.37% |
Latest transcript on ImmuCell Corporation
1 day | -0.59% | ||
Current month | -5.28% | ||
1 month | +1.21% | ||
3 months | -0.99% | ||
6 months | +0.10% | ||
Current year | -1.38% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Brigham
CEO | Chief Executive Officer | 63 | 89-08-31 |
Bobbi Brockmann
BRD | Director/Board Member | 48 | 09-12-31 |
Corporate Officer/Principal | 68 | 16-04-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Brigham
CEO | Chief Executive Officer | 63 | 89-08-31 |
David Tomsche
CHM | Chairman | 67 | 06-12-20 |
Bobbi Brockmann
BRD | Director/Board Member | 48 | 09-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 5.02 | -0.59% | 3,187 |
24-04-18 | 5.05 | 0.00% | 2,492 |
24-04-17 | 5.05 | 0.00% | 5,926 |
24-04-16 | 5.05 | -0.39% | 20,001 |
24-04-15 | 5.07 | +1.00% | 13,136 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-1.38% | 38.91M | |
-1.42% | 41.52B | |
+42.15% | 39.9B | |
+1.97% | 38.83B | |
-14.19% | 26.05B | |
+1.82% | 23.78B | |
-24.55% | 18.26B | |
-4.07% | 11.65B | |
+21.36% | 11.53B | |
+8.20% | 11.2B |
- Stock Market
- Equities
- ICCC Stock